Latest news
About $300M Cullgen deal adds cancer candidates to Gyre's pipeline - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTPress Release Service: Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates - CRISPR Medicine NewsCRISPR Medicine News · Fri, 07 Aug 2026 05:50:43 GMTLineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - Investing News NetworkInvesting News Network · Fri, 07 Aug 2026 03:33:59 GMTCorvus Eczema Trial Is Expected to Enroll About 200 Patients - Stock TitanStock Titan · Thu, 06 Aug 2026 23:04:17 GMTCytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:15:00 GMTCognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update - Yahoo! Finance CanadaYahoo! Finance Canada · Thu, 06 Aug 2026 20:15:00 GMTSolid Biosciences starts Duchenne Phase 3 trial; Phase 1/2 has 53 dosed - Stock TitanStock Titan · Thu, 06 Aug 2026 20:08:00 GMTRelmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:05:00 GMT